Stroke remains a major cause of death and adult disability worldwide. Global Burden of Disease (GBD) analyses report an overall decline in stroke risk of about 40% over the last 40 years, but this improvement has been concentrated in older adults. In absolute terms, stroke was a leading cause of mortality and disability in recent years, underscoring the continuing public health importance of prevention.
Although population ageing and growth project an overall rising burden of non-communicable disease, trends vary by age and geography. In some high-income settings such as the UK, population-based studies have reported slowing declines in stroke incidence and small but significant increases in younger age groups and in some ethnic minority communities.
A recent record-linkage study in England used routinely collected primary care, hospital, death certification, and national stroke audit data to estimate time trends in stroke incidence and modifiable risk factors. By combining multiple data sources, the investigators aimed to reduce ascertainment bias that arises when relying on a single dataset—an important consideration because a substantial proportion of people with stroke may not be hospitalised, particularly during periods such as the COVID-19 pandemic.
The linked-data approach produced estimates showing an approximately doubling of stroke risk in adults younger than 55 years over the last five years. The study also found that the all-age increase in stroke risk was more modest (around 10%), a pattern consistent with reduced hospital admissions and shifting health‑seeking behaviours during the pandemic years. The rise in younger adults was partly attributed to increasing incidence in ethnic minority populations.
It is well established that conventional cardiovascular risk factors—hypertension, diabetes, obesity, smoking, raised cholesterol, and atrial fibrillation—substantially increase stroke risk and are common in many populations. Improvements in detection and control of several of these risk factors have been credited with much of the historical decline in stroke incidence.
National surveillance data show mixed trends: declines in smoking prevalence, hypertension, raised cholesterol, and body mass index in some settings, alongside increases in atrial fibrillation prevalence and persistent problems with diabetes and obesity. The observed rise in stroke among younger adults suggests gaps remain in primary prevention, early detection, and long-term management of established risk factors.
Beyond the classical clinical factors, a range of emerging risks and social determinants likely influence contemporary stroke trends. These include air pollution, climate change–related extreme heat, early-life disadvantage, poverty, low socioeconomic status, and widening inequalities. Ethnic minority and deprived communities are disproportionately affected by many of these determinants.
Each country or region will have a distinct mix of clinical, environmental, and social drivers, arguing for locally tailored prevention strategies rather than one-size-fits-all policies.
Interpreting recent trends is complicated by the effects of the COVID-19 pandemic. During the pandemic, reduced hospital admissions and altered patterns of care likely affected case ascertainment in many routine data sources. Studies, including the GBD analyses, reported a stabilisation of stroke incidence rates during pandemic years, suggesting that routine sources may have preferentially captured hospitalised cases.
While linked datasets mitigate some biases, disentangling pandemic-related artefacts from true changes in incidence remains challenging. The record-linkage study reported a large increase in younger adults but acknowledged the difficulty of separating pandemic influences from other causes.
Current cardiovascular risk prediction algorithms heavily weight age and therefore often score adults under 40 as low short-term risk. This age-dominant approach can under-recognise younger people with clinically important or socially driven lifetime risk. The implications are that many younger adults may not be identified for preventive interventions despite rising incidence.
Potential adjustments include expanding risk algorithms to incorporate additional clinical, behavioural, and socioeconomic variables for people in their 20s, 30s, and 40s; improving opportunistic and systematic detection of risk factors in younger populations; and intensifying primary prevention programmes at scale.
Tailored public health education and culturally sensitive screening strategies are needed to address ethnic and socioeconomic disparities and to improve uptake of screening, engagement with care, medication adherence, and ongoing monitoring.
Key gaps and priorities identified include:
Despite effective treatments for many established stroke risk factors, recent linked-data evidence from the UK indicates a worrying increase in stroke risk among adults younger than 55 years, with roughly a doubling of risk over the past five years. This trend, together with emerging environmental and social determinants, highlights the need to rethink risk assessment and prevention strategies for younger people. More accurate risk algorithms, expanded primary prevention programmes, and targeted, culturally sensitive interventions will be required to address both traditional and newly prominent drivers of stroke risk.